Clinical Trials · NCT02054637

Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy

UnknownPhase 2Lanreotide (Unclear)
Phase
Phase 2
Recruitment status
Unknown
Sponsor
Universitair Ziekenhuis Brussel
Enrollment
10
Start date
Apr 2014
Locations
1 site, Belgium
Primary endpoint
Los Angeles criteria for reflux esophagitis
View Lanreotide compound reference